Guangdong Kanghua Healthcare Group Valuation

Q: What is the Fair Price of 3689 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

3689 (HK$2.35) is trading below our estimate of [[fair value]] (HK$6.04)

Is 3689 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 3689 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3689 (HK$2.35) is trading below our estimate of fair value (HK$6.04)

Significantly Below Fair Value: 3689 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3689?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 3689. This is calculated by dividing 3689's market cap by their current preferred multiple.
What is 3689's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CN¥714.79m

3689 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.2x
Enterprise Value/EBITDA	2.1x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 3689's PE Ratio compare to its peers?

The above table shows the PE ratio for 3689 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	19.8x
383 Tian An Medicare	27.5x	n/a	HK$868.8m
2120 Wenzhou Kangning Hospital	10.7x	n/a	HK$1.1b
2189 Kato (Hong Kong) Holdings	8.1x	n/a	HK$520.0m
9906 Honliv Healthcare Management Group	32.8x	n/a	HK$1.2b
3689 Guangdong Kanghua Healthcare Group	14.1x	n/a	HK$785.8m

Price-To-Earnings vs Peers: 3689 is good value based on its Price-To-Earnings Ratio (14.1x) compared to the peer average (19.8x).

Price to Earnings Ratio vs Industry

How does 3689's PE Ratio compare vs other companies in the HK Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	19.2%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	19.2%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: 3689 is expensive based on its Price-To-Earnings Ratio (14.1x) compared to the Hong Kong Healthcare industry average (13.1x).

Price to Earnings Ratio vs Fair Ratio

What is 3689's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3689 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	14.1x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 3689's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.